Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: A comparison with effects of the adjuvant radiotherapy

Obstetrics and Gynecology

Volumn 91, Issue 6, 1998, Pages 977-981

  Iwasaka, Tsuyoshi ^a   Kamura, Toshiharu ^b   Yokoyama, Masatoshi ^a   Matsuo, Norihito ^a   Nakano, Hitoo ^b   Sugimori, Hajime ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN C; PEPLEOMYCIN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK FACTOR; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PEPLOMYCIN; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 0031833608     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00079-9     Document Type: Article

References (20)

1. Hogan W.M., Littman P., Griner L., Miller C.L., Mikurta J.J. Results of radiation therapy given after radical hysterectomy. Cancer. 49:1982;1278-1285.
2. Gauthier P., Gore I., Shingleton H.M., Soong S.J., Orr J.W. Jr, Hatch K.D. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol. 66:1985;569-574.
3. Wertheim M.S., Hakes T.B., Daghestani A.N., Nori D., Smith D.H., Lewis J.L. Jr. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 3:1985;912-916.
4. Fuller A.F. Jr, Elliott N., Kosloff C., Hoskins W.J., Lewis J.L. Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 33:1989;34-39.
5. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K., et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186.
6. Gerdin E., Cnattingius S., Johnson P., Pettersson B. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol. 53:1994;314-319.
7. Monk B.J., Cha D.S., Walker J.L., Burger R.A., Ramsinghani N.S., Manetta A., et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol. 54:1994;4-9.
8. Russell A.H., Tong D.Y., Figge D.C., Tamimi H.K., Greer B.E., Elder S.J. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix Pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy . Int J Radiat Oncol Biol Phys. 10:1984;211-214.
9. Shiromizu K., Matsuzawa M., Takahashi M., Ishihara O. Is postoperative radiotherapy or maintenance chemotherapy necessary for carcinoma of the uterine cervix? Br J Obstet Gynaecol. 95:1988;503-506.
10. Lahousen M., Pickel H., Haas J. Adjuvant chemotherapy after radical hysterectomy for cervical cancer. Baillieres Clin Obstet Gynaecol. 2:1988;1049-1057.
11. Lai C.H., Lin T.S., Soong Y.K., Phil M., Chen H.F. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 35:1989;193-198.
12. Sivanesaratnam V., Jayalakshmi P. Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer. Cancer. 64:1989;798-800.
13. Tattersall M.H.N., Ramirez C., Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol. 46:1992;176-181.
14. Sugimori H., Iwasaka T., Fukuda K., Hayashi Y., Hachisuga T. Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C and cisplatin. Gynecol Oncol. 34:1989;180-182.
15. Vogl S.E., Moukhtar M., Calanog A., Greenwald E.H., Kaplan B.H. Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP). Cancer Treat Rep. 64:1980;1005-1007.
16. Dishe S. Radiotherapy of cervical cancer. Clin Obstet Gynecol. 12:1985;203-227.
17. Barter J.F., Soong S.J., Shingleton H.M., Hatch K.D., Orr J.W. Jr. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol. 32:1989;292-296.
18. Larson D.M., Stringer C.A., Copeland L.J., Gershenson D.M., Malone J.M. Jr, Rutledge F.N. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy Role of adjuvant radiotherapy . Obstet Gynecol. 69:1987;378-381.
19. Monaghan J.M., Ireland D., Mor-Yosef S., Pearson S.E., Lopes A., Sinha D.P. Role of centralization of surgery in stage IB carcinoma of the cervix A review of 498 cases . Gynecol Oncol. 37:1990;206-209.
20. Soisson A.P., Soper J.T., Clarke-Pearson D.L., Berchuck A., Montana G., Creasman W.T. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 37:1990;390-395.